Interrogating basal ganglia circuit function in people with Parkinson's disease and dystonia.
Parkinson's disease
basal ganglia
deep brain stimulation
dystonia
human
medicine
neuroscience
single-neuron
synaptic plasticity
Journal
eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614
Informations de publication
Date de publication:
27 Aug 2024
27 Aug 2024
Historique:
medline:
27
8
2024
pubmed:
27
8
2024
entrez:
27
8
2024
Statut:
epublish
Résumé
The dichotomy between the hypo- versus hyperkinetic nature of Parkinson's disease (PD) and dystonia, respectively, is thought to be reflected in the underlying basal ganglia pathophysiology. In this study, we investigated differences in globus pallidus internus (GPi) neuronal activity, and short- and long-term plasticity of direct pathway projections. Using microelectrode recording data collected from the GPi during deep brain stimulation surgery, we compared neuronal spiketrain features between people with PD and those with dystonia, as well as correlated neuronal features with respective clinical scores. Additionally, we characterized and compared readouts of short- and long-term synaptic plasticity using measures of inhibitory evoked field potentials. GPi neurons were slower, bustier, and less regular in dystonia. In PD, symptom severity positively correlated with the power of low-beta frequency spiketrain oscillations. In dystonia, symptom severity negatively correlated with firing rate and positively correlated with neuronal variability and the power of theta frequency spiketrain oscillations. Dystonia was moreover associated with less long-term plasticity and slower synaptic depression. We substantiated claims of hyper- versus hypofunctional GPi output in PD versus dystonia, and provided cellular-level validation of the pathological nature of theta and low-beta oscillations in respective disorders. Such circuit changes may be underlain by disease-related differences in plasticity of striato-pallidal synapses. This project was made possible with the financial support of Health Canada through the Canada Brain Research Fund, an innovative partnership between the Government of Canada (through Health Canada) and Brain Canada, and of the Azrieli Foundation (LM), as well as a grant from the Banting Research Foundation in partnership with the Dystonia Medical Research Foundation (LM).
Sections du résumé
Background
UNASSIGNED
The dichotomy between the hypo- versus hyperkinetic nature of Parkinson's disease (PD) and dystonia, respectively, is thought to be reflected in the underlying basal ganglia pathophysiology. In this study, we investigated differences in globus pallidus internus (GPi) neuronal activity, and short- and long-term plasticity of direct pathway projections.
Methods
UNASSIGNED
Using microelectrode recording data collected from the GPi during deep brain stimulation surgery, we compared neuronal spiketrain features between people with PD and those with dystonia, as well as correlated neuronal features with respective clinical scores. Additionally, we characterized and compared readouts of short- and long-term synaptic plasticity using measures of inhibitory evoked field potentials.
Results
UNASSIGNED
GPi neurons were slower, bustier, and less regular in dystonia. In PD, symptom severity positively correlated with the power of low-beta frequency spiketrain oscillations. In dystonia, symptom severity negatively correlated with firing rate and positively correlated with neuronal variability and the power of theta frequency spiketrain oscillations. Dystonia was moreover associated with less long-term plasticity and slower synaptic depression.
Conclusions
UNASSIGNED
We substantiated claims of hyper- versus hypofunctional GPi output in PD versus dystonia, and provided cellular-level validation of the pathological nature of theta and low-beta oscillations in respective disorders. Such circuit changes may be underlain by disease-related differences in plasticity of striato-pallidal synapses.
Funding
UNASSIGNED
This project was made possible with the financial support of Health Canada through the Canada Brain Research Fund, an innovative partnership between the Government of Canada (through Health Canada) and Brain Canada, and of the Azrieli Foundation (LM), as well as a grant from the Banting Research Foundation in partnership with the Dystonia Medical Research Foundation (LM).
Identifiants
pubmed: 39190604
doi: 10.7554/eLife.90454
pii: 90454
doi:
pii:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023, Sumarac, Spencer, Steiner et al.
Déclaration de conflit d'intérêts
SS, KS, LS, CF, EH, AK, MH, SK, AL, AF, WH, LM No competing interests declared
Références
Mov Disord. 2016 Nov;31(11):1748-1751
pubmed: 27548068
Brain Res. 1971 Sep 10;32(1):229-33
pubmed: 4329652
Mov Disord Clin Pract. 2014 Nov 04;2(1):99-101
pubmed: 30363825
Neuroreport. 1994 Jul 21;5(12):1533-7
pubmed: 7948856
J Neurosci. 2018 May 9;38(19):4556-4568
pubmed: 29661966
Arch Neurol. 2005 Apr;62(4):554-60
pubmed: 15824252
Mov Disord. 2013 Jun 15;28(7):863-73
pubmed: 23649720
J Neurophysiol. 2007 Aug;98(2):720-9
pubmed: 17537900
Motor Control. 2009 Oct;13(4):442-53
pubmed: 20014649
Bioelectron Med. 2024 Jan 10;10(1):2
pubmed: 38195618
Ann Neurol. 2003 Apr;53(4):480-8
pubmed: 12666115
J Neurophysiol. 2005 Jun;93(6):3165-76
pubmed: 15703229
J Neurosci. 2013 Sep 11;33(37):14705-14
pubmed: 24027271
Neurobiol Dis. 2019 Apr;124:46-56
pubmed: 30391540
J Neurosci Methods. 1996 Oct;68(2):211-23
pubmed: 8912194
Exp Neurol. 2021 Nov;345:113825
pubmed: 34331900
Can J Neurol Sci. 1993 Aug;20(3):177-83
pubmed: 8221380
Trends Neurosci. 1990 Jul;13(7):281-5
pubmed: 1695404
Ann Neurol. 2006 Jan;59(1):60-71
pubmed: 16240372
Exp Neurol. 2016 May;279:187-196
pubmed: 26946223
Nat Neurosci. 2017 Jun;20(6):815-823
pubmed: 28481350
Neurobiol Dis. 2004 Jun;16(1):236-45
pubmed: 15207280
Mov Disord. 1998 Mar;13(2):319-23
pubmed: 9539347
Neurobiol Dis. 2013 Mar;51:214-21
pubmed: 23201208
Arch Neurol. 1998 May;55(5):601-3
pubmed: 9605716
Brain Stimul. 2022 Sep-Oct;15(5):1223-1232
pubmed: 36058524
Philos Trans R Soc Lond B Biol Sci. 2015 Jul 5;370(1672):
pubmed: 26009763
Brain Res. 1971 Sep 10;32(1):225-8
pubmed: 4329651
Neuron. 2019 Mar 20;101(6):1042-1056
pubmed: 30897356
Mov Disord. 2011 Aug 15;26(10):1913-21
pubmed: 21547950
Brain. 2009 Mar;132(Pt 3):749-55
pubmed: 19151081
Brain. 2011 Jul;134(Pt 7):2106-15
pubmed: 21705425
Brain. 2017 Dec 1;140(12):3179-3190
pubmed: 29087445
N Engl J Med. 2010 Jun 3;362(22):2077-91
pubmed: 20519680
J Neurol Neurosurg Psychiatry. 2016 Jul;87(7):717-21
pubmed: 26424898
Brain. 2014 Nov;137(Pt 11):3012-3024
pubmed: 25212852
J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):368-76
pubmed: 18344392
Stereotact Funct Neurosurg. 2002;78(3-4):168-82
pubmed: 12652041
Brain. 2018 Jan 1;141(1):177-190
pubmed: 29236966
Ann Neurol. 2017 Dec;82(6):912-924
pubmed: 29130551
Neurobiol Dis. 2010 Mar;37(3):558-73
pubmed: 20005952
Brain. 2003 Dec;126(Pt 12):2597-608
pubmed: 12937079
Neurology. 1999 Feb;52(3):529-37
pubmed: 10025782
Neurobiol Dis. 2014 Nov;71:24-33
pubmed: 25116960
J Neurophysiol. 2012 Jul;108(1):5-17
pubmed: 22457462
J Neurosurg. 2000 Apr;92(4):615-25
pubmed: 10761650
Trends Neurosci. 2007 Jul;30(7):357-64
pubmed: 17532060
Muscle Nerve Suppl. 2000;9:S26-32
pubmed: 11135281
Arch Neurol. 2007 Jan;64(1):20-4
pubmed: 17210805
Science. 2021 Oct 08;374(6564):201-206
pubmed: 34618556
Parkinsonism Relat Disord. 2017 Oct;43:97-100
pubmed: 28712731
Eur J Neurosci. 2019 Mar;49(6):805-816
pubmed: 30044030
Proc Natl Acad Sci U S A. 2022 Aug 30;119(35):e2205881119
pubmed: 36018837
Brain. 2009 Sep;132(Pt 9):2336-49
pubmed: 19641103
Neurobiol Dis. 2011 May;42(2):162-70
pubmed: 21168494